Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Jeffrey Fudin"'
Autor:
Jeffrey Gudin, Jeffrey Fudin
Publikováno v:
Pain and Therapy, Vol 9, Iss 1, Pp 41-54 (2020)
Abstract Buprenorphine is a Schedule III opioid analgesic with unique pharmacodynamic and pharmacokinetic properties that may be preferable to those of Schedule II full μ-opioid receptor agonists. The structure of buprenorphine allows for multimecha
Externí odkaz:
https://doaj.org/article/d1bda8800c9d44888e8d6c0f2227d354
Publikováno v:
Medicine Access @ Point of Care, Vol 4 (2020)
Patients with chronic pain syndromes are facing additional challenges from syndrome coronavirus 2 (SARS-CoV-2) virus compared with the general population. New reasons for compounded social isolation and commensurate opioid dose creeping and suicidali
Externí odkaz:
https://doaj.org/article/d1dd6db558264199868875c3c13638b9
Publikováno v:
Medicine Access @ Point of Care, Vol 3 (2019)
Over the past decade, opioid use has been at the forefront of a public health crisis throughout the United States. In response to the tremendous negative societal, personal, and economic impacts that the growing opioid crisis has caused, several gove
Externí odkaz:
https://doaj.org/article/b588944c5c2a40b5ad56ce35599ce71d
Autor:
Mônica R. Gadelha, Niki Karavitaki, Jeffrey Fudin, Jeffrey J. Bettinger, Hershel Raff, Anat Ben-Shlomo
Publikováno v:
Pituitary. 25:52-63
Opioids are highly addictive potent analgesics and anti-allodynics whose use has dramatically increased in recent decades. The precipitous rise in opioid dependency and opioid use disorder is an important public health challenge given the risks for s
Autor:
Michelle Wood, W. Michael Hooten, Thomas G. Rosano, Charles Argoff, John M Rumberger, Jeffrey Fudin
Publikováno v:
Pain Medicine. 23:821-833
Objective To assess routine application and clinical value of definitive urine drug monitoring (UDM) for drug detection, inconsistent drug use, and prescription adherence, along with a comparison to immunoassay screening (IAS). Methods Direct-to-defi
Publikováno v:
Journal of Pain Research
Amelia L Persico,1,2 Jeffrey J Bettinger,2,3 Erica L Wegrzyn,2,4 Jeffrey Fudin,2,4 Scott A Strassels5,6 1Shields Health Solutions, Stoughton, MA, 02072, USA; 2Remitigate Therapeutics, Delmar, NY, 12054, USA; 3Saratoga Hospital Medical Group, Saratoga
Publikováno v:
Journal of Opioid Management. 17:11-14
Publikováno v:
Journal of Pain Research.
Jeffrey Fudin,1â 3 Kip Vought,4 Kalpana Patel,4 Dmitri Lissin,4 Howard Maibach5 1Pain Management and PGY2 Pharmacy Pain Residency, Samuel Stratton Department of Veterans Affairs Medical Center, Albany, NY, USA; 2Remitigate Therapeutics, Delmar,
Publikováno v:
Journal of Pain Research
The interest in substances that stimulate respiration has waxed and waned throughout the years, intensifying following the introduction of a new class of drugs that causes respiratory depression, and diminishing when antidotes or better drug alternat
Publikováno v:
Journal of pain and symptom management. 64(6)
In this article, we provide an overview of pharmacists' involvement with palliative care, starting with recent history, up to present day. The aim of this review is to highlight advances in the field of palliative care pharmacy and the integral role